Caricamento...

Determinants of Human Immunodeficiency Virus Type 1 Baseline Susceptibility to the Fusion Inhibitors Enfuvirtide and T-649 Reside outside the Peptide Interaction Site

The peptide fusion inhibitor (PFI) enfuvirtide is the first of a new class of entry inhibitors to receive FDA approval. We previously determined the susceptibility of 55 PFI-naïve-patient isolates to enfuvirtide and a second peptide inhibitor, T-649. Seven of the 55 viral isolates were insusceptible...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Heil, Marintha L., Decker, Julie M., Sfakianos, Jeffrey N., Shaw, George M., Hunter, Eric, Derdeyn, Cynthia A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2004
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC434069/
https://ncbi.nlm.nih.gov/pubmed/15220433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.14.7582-7589.2004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !